References
Åberg, A. and Holmberg, G: Preliminary clinical test of zimelidine (H 102/09), a new 5-HT uptake inhibitor. Acta Psychiatrica Scandinavica 59: 45 ( 1979).
Albertini, R.S. and Penders, T.M.: Agranulocytosis associated with tricyclics. Journal of Clinical Psychiatry 39: 483 (1978).
Anath, j. and Luchins, D.J.: Combined MAOI-tricyclic therapy (a critical review). Indian Journal of Psychiatry 18: 26 (1976).
Appel, P.; Eckel, K. and Harrer, G.: Veranderungen des blasen-und blasensphinktestonus durch thymoleptika. International Pharmacopsychiatry 6: 15 (1971).
Barnes, T.R.E. and Greenwood, D.T.: Viloxazine and migraine. Lancet 2: 1368(1979).
Biggs, J.T.: Clinical pharmacology and toxicology of antidepres-sants. Hospital Practice 13: 79 (1978).
Blackwell, B.: Hypertensive crisis due to MAOI. Lancet 2: 849–851 (1963).
Blackwell, B.: The process of discovery; in Ayd and Blackwell (Eds) Discoveries in Biological Psychiatry, pp.11–29 (Lippin-cott, Philadelphia and Toronto 1970).
Blackwell, B.: Antidepressant drugs; in Dukes (Ed) Side Effects of Drugs Annual I, pp.9–16 (Excerpta Medica, Amsterdam-Oxford 1977).
Blackwell, B.: Antidepressant drugs; in Dukes (Ed) Side Effects of Drugs Annual 2, pp. 9–16 (Excerpta Medica, Amsterdam-Oxford 1978).
Blackwell, B.: MHPG in depression. Psychiatric Opinion 16: 2 (1979a).
Blackwell, B.: Antidepressant drugs; in Dukes (Ed) Side Effects of Drugs Annual 3, pp.8–21 (Excerpta Medica, Amsterdam-Oxford 1979b).
Blackwell, B.: The drug regimen and treatment compliance; in Haynes, Taylor, and Sackett (Eds) Compliance in Health Care, pp.144–156 (Johns Hopkins University Press, Baltimore 1979c).
Blackwell, B.: Antidepressant drugs; in Dukes (Ed) Side Effects of Drugs Annual 4, pp. 17–21 (Excerpta Medica, Amsterdam-Oxford 1980).
Blackwell, B.: Antidepressant drugs; in Dukes (Ed) Side Effects of Drugs Annual 5 (Excerpta Medica, Amsterdam-Oxford, In press 1981).
Blackwell, B. and Currah, J.: The psychopharmacology of nocturnal enuresis; in Kolvin, MacKeith and Meadow (Eds) Bladder Control and Enuresis, pp.213–257, Clinics in Developmental Medicine No. 48/49 (Heinemann, London 1973).
Blackwell, B.; Marley, E.; Price, J. and Taylor, D.: Hypertensive interactions between monoamine oxidase inhibitors and food stuffs. British Journal of Psychiatry 113: 349–365 (1967).
Blackwell, B.; Lipkin, J.O.; Meyer, J.H. and Kuzma, R.: Dose responses and relationships between anticholinergic side effects and mood with tricyclic antidepressants. Psychopharmacologia 25: 205–217 (1972).
Blackwell. B.; Stepfopoulos, A.; Enders, P.; Kuzma, R. and Adolphe, A.; Adolphe, A.: The anticholinergic activity of two tricyclic anti-depressants. American Journal of Psychiatry 135: 722–724 (1978).
Blackwell, B.; Peterson, G.R.; Kuzma, R.J. and Adolphe, A.: The effect of five tricyclic antidepressants on salivary flow and mood in healthy volunteers. Submitted for publication (1980).
Boston Collaborative Drug Surveillance Program Report. Adverse reactions to tricyclic antidepressant drugs. Lancet 1: 529–531 (1972).
Bournerias, F. and Habibi, B.: Nomifensine-induced immune haemolytic anaemia and impaired renal function. Lancet 2. 95 (1979).
Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 18: 1–24 (1979a).
Brogden, R.N.; Heel, R.C.; Speight, T.M. and Avery, G.S.: Mian-serin A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16: 273–301 (1979b).
Burgess, CD.; Montgomery, S.; Wadsworth, J. and Turner, P.: Cardiovascular effects of mianserin, zimelidine, nomifensine in depressed patients. Postgraduate Medical Journal 55: 704–708(1979).
Burrows, G.D.; Vohra, J.; Dumovic, P.; Maguire, K.; Scoggins, B.A. and Davies, B.: Tricyclic antidepressant drugs and cardiac conduction. Progress in Neuro-Psychopharmacology 1: 329(1977).
Callahan, M.: Tricyclic antidepressant overdose. Journal of American College of Emergency Physicians 8: 413–35 ( 1979).
Carney, M.W.P.: Tricyclics and the heart. British Journal of Psychiatry 134: 637–639(1979).
Carr, A.C. and Hobson, R.P.: High serum concentrations of antidepressants in elderly patients. British Medical Journal 2: 1151 (1978).
Chouinard, G. and Jones, B.D.: Neuroleptic-induced supersen-sitivity psychosis: Clinical and pharmacologic characteristics. American Journal of Psychiatry 137: 16–21 (1980).
Clarke, I.M.C.: Adynamic ileus and amitriptyline. British Medical Journal 2: 531 (1971).
Coppen, A.; Shaw, D.M. and Farrell, J.P.: Potentiation of the an-tidepressive effect of a monoamine oxidase inhibitor by tryp-tophan. Lancet 1: 79–81 (1963).
Connell, P.H.: Amphetamine psychosis; in Maudley Monograph No. 5, (Oxford University Press, London 1958).
Crombie, D.L.; Pinsent, R.J. and Fleming, D.: Imipramine in pregnancy. British Medical Journal 1: 745 (1972).
Crome, P. and Newman, B.: Fatal tricyclic antidepressant poisoning. Journal of the Royal Society of Medicine 72: 649–653 (1979).
Davies, R.K.; Tucker, E.J.; Harrow, M. and Detre, T.P.: Confu-sional episodes and antidepressant medication. American Journal of Psychiatry 128: 127 ( 1971).
DeMaio, D. and Levi-Minzi, A.: Amitriptyline: A comparison of three different dosage schedules in neurotic depression. British Journal of Psychiatry 135: 73–76 (1979).
Detre, P. and Jarecki, H.G. (Eds): Modern Psychiatric Treatment, pp.614–620 (Lippincott, Philadelphia and Toronto 1971).
Editorial: Tricyclic antidepressant concentrations and clinical dosage. British Medical Journal 2: 783 (1978).
Editorial: Tricyclic antidepressant poisoning in children. Lancet 2: 1116(1979).
Edwards, G.J.: Convulsive seizures and viloxazine. British Medical Journal 2: 96(1977).
Edwards, J.G.: Antidepressants and convulsions. Lancet 2: 1368–1369(1979).
Fabre, L.F.; McLendon, D.M. and Gainey, A.: Trazadone efficacy in depression. A double-blind comparison with impramine and placebo in day hospital type patients. Current Therapeutic Research 25: 827–834(1979).
Fann, W.E.; Sullivan, J. and Richman, B.W.: Dyskinesias associated with tricyclic antidepressants. British Journal of Psychiatry 128: 490(1976).
Flemenbaum, A.: Pavor nocturnus: A complication of single daily tricyclic or neuroleptic dosage. American Journal of Psychiatry 133: 570 (1976).
Forrest, W.A.: Maprotiline (Ludiomil) in depression: A report of a monitored release study in general practice. Journal of International Medical Research 5 (Suppl. 4): 112 (1977).
Fu, Tsu-Ker; Jarvik, L.F.; Yen, Fu-Sun; Matsuyama, S.S.; Glassman, A.H.; Perel, J.M. and Malitz, S.: Effects of imipramine on chromosomes in psychiatric patients. Neuropsychobiology 4: 113(1978).
Gelenberg, A.J.; Cooper, D.S.; Doller, J.C. and Maloof, F.: Galac-torrhea and hyperprolactinemia associated with amoxapine therapy. Journal of the American Medical Association 242: 1900–1901 (1979).
Gilani, S.H.: Imipramine and congenital abnormalities. Pathologic Microbiology (Basel) 40: 37 (1974).
Glassman, A.H.; Giardina, E.V.; Perel, J.M.; Bigger, J.T. Jr; Kantor, S.J. and Davies, M.: An important side effect of imipramine: Postural hypotension. Lancet 1: 468–472 (1979).
Goldberg, R.S. and Thornton, W.E.: Combined tricyclic-MAOI therapy for refractory depression: A review, with guidelines for appropriate usage. Journal of Clinical Pharmacology 18: 143(1978).
Gulevich, G.: Psychopharmacological treatment of the aged; in Barelos et al. (Eds) Psychopharmacology pp.448–457 (Oxford University Press, New York 1977).
Harris, B. and Harper, M.: Unusual appetites in patients on mian-serin. Lancet 1: 590(1980).
Hayes, J.R.; Born, G.F. and Rosebaum, A.H.: Incidence of orthostatic hypotension in patients with primary affective disorders treated with tricyclic antidepressants. Mayo Clinic Proceedings 52: 509 (1977).
Heath, A.; Wickstrom, I. and Ahlem, J.: Haemoperfusion of tricyclic antidepressant poisoning. Lancet 1: 155 (1980).
Herson, V.C.; Schmitt, B.D. and Rumack, B.H.: Magical thinking and Imipramine poisoning in two school-age children. Journal of the American Medical Association 241: 1926 (1979).
Hoppe, E.; Kramp, P.; Sand, E. and Bolwig, T.G.: Elektrokon-vulsiv behandling og tricykliske antidepressiva: Risiko for udvikling af Hjerteartmi. Ugeskrift For Laeger (Copenhagen) 139: 2636(1977).
Idanpaan-Heikkila, J. and Saxen, L.: Possible teratogenicity of imipramine/chloropyramine. Lancet 2: 282(1973).
Jaffe, K. and Zisook, S.: Galactorrhea in a patient treated with amoxapine. Journal of Clinical Psychiatry 39: 321 (1979).
Johnson, D.A.W.: Treatment of depression in general practice. British Medical Journal 2: 18–20 (1973).
Kantor, S.J.; Bigger, J.T.; Glassman, A.H.; Macken, D.L. and Perel, J.M.: Imipramine-induced heart block: A longitudinal case study. Journal of the American Medical Association 213: 1364(1975).
Kantor, S.J.; Glassman, AH.; Bigger, J.T.; Perel, J.M. and Giardina, E.V. The cardiac effects of therapeutic plasma concentration of imipramine. American Journal of Psychiatry 135: 534(1978).
Kaumeier, H.S. and Haase, H.J.: A double-blind comparison between amoxapine and amitriptyline in depressed inpatients. International Journal of Clinical Pharmacology 18: 177–184 (1980).
Kellams, J.J.; Klapper, M.H. and Small, J.G.: Trazadone, a new antidepressant: Efficacy and safety in endogenous depression. Journal of Clinical Psychiatry 3.9: 390–395 (1979).
Klatskin, G.: In Schaffner, Sherlock and Leevy (Eds) The liver and Its Diseases, p.163 (Stuttgart 1974); and in Schiff (Ed) Diseases of the Liver, p.604 (Lippincott, Philadelphia 1974).
Kline, N.: Monoamine oxidase inhibitors: An unfinished picaresque tale; in Ayd and Blackwell (Eds) Discoveries in Biological Psychiatry, pp. 194–204 (Lippincott, Philadelphia and Toronto 1970).
Kopera, H.: Anticholinergic effects of mianserin. Current Medical Research and Opinion 6 (Suppl. 7): 132–138 (1980).
Kozakova, M.: Liekova purpura po antidepresivach. Ceskoslovenska Dermatologie 46: 158 (1971).
Kuenssberg, E.V. and Knox, J.D.E.: Imipramine in pregnancy. British Medical Journal 2: 292 (1972).
Kuhn, R.: The imipramine story; in Ayd and Blackwell (Eds) Discoveries in Biological Psychiatry, pp.205–217 (Lippincott, Philadelphia and Toronto 1970).
Lloyd, A.H.: Practical considerations in the use of maprotiline (Ludiomil) in general practice. Journal of International Medical Research 5 (Suppl. 4): 122 (1977).
McBride, N.G.: Limb deformities associated with iminodibenzyl hydrochloride. Medical Journal of Australia 1: 492 (1972).
Meignan, L.: Anesthesie et anti-depresseurs tri-cycliques. Cahiers d’Anesthesiologie 25: 735 (1977).
Moir, D.C.; Crooks, J; Cornewell, W.B.; O’Malley, K., Ding-wall-Fordyce; Turnbull, M.J. and Weir, R.D.: Cardiotoxicity of imipramine. Lancet 2: 561–564 (1972).
Montgomery, S.; Crome, P. and Braithwaite, R.: Nomifensine overdose. Lancet 1: 828 (1978).
Nakra, B.R.; Rutland, P.; Verma, S. and Gaind, R.: Amitripyline and weight gain: A biochemical and endocrinological study. Current Medical Research and Opinion 4: 602 (1977).
Nouri, A. and Cuendet, J.F.: A heintes oculaires au cours des traitements aux hypnoleptiques. Schweizerische Medizinische Wochenschrift Journal Suisse De Medecine (Basel) 101: 1178 (1971).
Norman, T.R.; Burrows, G.D.; Scroggins, B.A. and Davies, B.: Pharmacokinetics and plasma levels of antidepressants in the elderly. Medical Journal of Australia 1: 273–274 (1979).
O’Brien, J.P.: A study of low-dose amitriptyline overdose. American Journal of Psychiatry 134: 66 (1977).
Palmai, CT.; Blackwell, B.; Maxwell, A.E. and Morgenstern, F.: Patterns of salivary flow in depressive illness and during treatment. British Journal of Psychiatry 113: 1297–1308 (1967).
Pare, C.M.B.: Monoamine oxidase inhibitors in resistant depression. International Pharmacopsychiatry 14: 101–109(1979).
Paykel, E.S.; Meuller, P.S. and De La Vergne, P.M.: Amitriptyline, weight gain and carbohydrate craving: A side effect. British Journal of Psychiatry 123: 501 (1973).
Paykel, E.S.; Parker, R.R.; Penrose, R.J.J. and Rassaby, E.R.: Depressive classification and prediction of response to phenelzine. British Journal of Psychiatry 134: 572–581 (1979).
Pedersen, R.S.: Hemoperfusion of tricyclic antidepressant poisoning. Lancet 1: 154(1980).
Petit, J.M.; Spiker, D.G.; Ruwitch, J.F.; Ziegler, V.E.; Weiss, A.N. and Biggs, J.T.: Tricyclic antidepressant plasma levels and adverse effects after overdose. Clinical Pharmacology and Therapeutics 21: 47 (1977).
Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S.: Viloxazine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 13: 401 (1977a).
Pinder, R.M.; Brogden, R.N.; Speight, T.M. and Avery, G.S. Maprotiline: A review of its pharmacological properties and therapeutic efficacy in mental depressive states. Drugs 13: 321 (1977b).
Pinder, R.M.; Blum, A.; Stulemeijer, S.M. et al.: A double-blind multicenter trial comparing the efficacy and side effects of mianserin and clomipramine in depressed inpatients and outpatients. Current Medical Research and Opinion 6 (Suppl 7): 115–127(1980).
Ponto, L.B.; Berry, P.J.; Liskow, B.I. and Seaba, H.H. Drug therapy review: Tricyclic antidepressant and monoamine oxidase inhibitor combination therapy. American Journal of Hospital Pharmacy 34: 954(1977).
Preskorn, S.H. and Biggs, J.T. Use of tricyclic antidepressant blood levels. New Engalnd Journal of Medicine 1: 166 (1978).
Prien, R.F.: Problems and practices in geriatric psychophar-macology. Psychosomatics 21: 213–223 (1980).
Reisby, N.; Gran, L.F.; Bech, P.; Nagy, A.; Petersen, G.O.; Ortman, J.; Ibsen, I.; Dencker, S.J. et al.: Imipramine: Clinical effects and pharmacokinetic variability. Psychopharmacology 54: 263 (1977).
Robinson, D.S.; Nies, A.; Ravaris, C.L.; Ives, J.O. and Bartlett, D: Clinical pharmacology and phenelzine. Archives of General Psychiatry 35: 629–635 (1978).
Salzman, C. and Shader, R.I: Drugs that may contribute to depression in the elderly; in Raskin and Jarvik (Eds) Psychiatric Symptoms and Cognitive Loss in the Elderly, pp.57–72 (Wiley, New York 1979).
Santos, A.B. and McCurdy, L.: Delirium after abrupt withdrawal from doxepin: Case report. American Journal of Psychiatry 137: 239–240(1980).
Schatzberg, A.F.; Cole, J.O. and Blumer, D.P. Speech blockage: A tricyclic side effect. American Journal of Psychiatry 135: 600(1978).
Sethi, B.B.; Sharma, I.; Singh, H. and Mehta, V.K. Amoxapine and amitriptyline: A double-blind study in depressed patients. Current Therapeutic Research 25: 726–737 (1979).
Shaw, W.L.: The comparative safety of mianserin in overdose. Current Medical Research and Opinion 6 (Suppl. 7): 44–51 (1980).
Shepherd, J.T. and Whiting, B. Beta-adrenergic blockage in the treatment of MAOI self-poisoning. Lancet 2: 1021 (1974).
Sitaram, N.; Weingartner, H. and Gillin, J.C.: Human serial learning: Enhancement with arecholine and choline and impairment with scopolamine. Science 201: 274–276 (1978).
Snyder, S.H. and Yamamura. H.I.: Antidepressants and the muscarinic acetylcholine receptor. Archives of General Psychiatry 34: 236(1977).
Solomon, J.G.: Seizures during lithium-amitriptyline therapy. Postgraduate Medicine 66: 145–148 (1979).
Sovner, R. and Orsulak, P.J.: Excretion of imipramine and desipramine in human breast milk. American Journal of Psychiatry 136: 451–452 (1979).
Stern, S.L. and Mendels, J.: Withdrawal symptoms during the course of imipramine therapy. Journal of Clinical Psychiatry 41:66–67(1980).
Takahashi, R.; Sakuma, A.; Hara, T.; Kazamatsuri, H.; Mori, A.; et al.: Comparison of efficacy of amoxapine and imipramine in a multi-clinic double-blind study using the WHO schedule depressive disorders. Journal of International Medical Research 7: 7 (1979).
Tyber, M.A.: The relationship between hiatus hernia and tricyclic antidepressants: A report of five cases. American Journal of Psychiatry 132(6): 652(1975).
Tyrer, B.; Gardner, M.; Lambourn, J. and Whitford, M.: Clinical and pharmacokinetic factors affecting response to phenelzine. British Journal of Psychiatry 136: 359–365 (1980).
Van De Ree, J.K.; Van Heijst, A.N.P.; Van Heijst, A.N.P.: Zimmerman, A.N.E. and Intoxication by tricyclic antidepressant drugs. Netherlands Journal of Medicine 20: 149 (1977).
Van Scheyen, J.D. and Van Kammen, D.P.: Clomipramine-induced mania in unipolar depression. Archives of General Psychiatry 36: 560–565(1979).
Van Vliet, A.C.M.; Frenkel, M. and Wilson, J.H.P.: Acute lever-insufficientie na Opipramolgebruik. Nederlands Tijdschrift Voor Geneeskunde (Amsterdam) 121: 1325 (1977).
Wasylenki, D.: Depression in the elderly. Canadian Medical Association Journal 122: 525–533 (1980).
Wehr, T.A. and Goodwin, F.K.: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Archives of General Psychiatry 36: 555–559 (1979).
Williams, W.: Mianserin reverses weight gain associated with amitriptyline. Medical Journal of Australia 1: 132 (1980).
Wright, S.P.: Hazards with monoamine oxidase inhibitors: A persistent problem. Lancet 1: 284 (1978).
Yon, J. and Anuras, S.: Hepatitis caused by amitriptyline therapy. Journal of the American Medical Association 232: 833 (1975).
Young, J.P.R.; Lader, M.H. and Hughes, W.C.: Controlled trial of trimipramine, monoamine oxidase inhibitors and combined treatments in depressed outpatients. British Medical Journal 2: 1315–1319(1979).
Young, J.P.R.; Lader, M.H. and Hughes, W.C.: Controlled trial of trimipramine, monoamine oxidase inhibitors and combined treatments in depressed outpatients. British Medical Journal 2: 1315–1319(1979).
Ziegler, V.E.; Taylor, J.R.; Wetzel, R.D. and Biggs, J.T.: Nortrip-tyline plasma levels and subjective side effects. British Journal of Psychiatry 132: 55 (1978).
Zis, A.P. and Goodwin, F.K.: Novel antidepressants and the biogenic amine hypothesis of depression. Archives of General Psychiatry 36: 1097–1107(1979).
Zis, A.P.; Cowdry, R.W.; Wehr, T.A.; Muscettola, G. and Goodwin, FK Tricyclic-induced mania and MHPG excretion. Psychiatric Research 1: 93–99 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blackwell, B. Adverse Effects of Antidepressant Drugs. Drugs 21, 273–282 (1981). https://doi.org/10.2165/00003495-198121040-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198121040-00003